跳转至内容
Merck
所有图片(1)

主要文件

1269221

USP

Famotidine Related Compound B

United States Pharmacopeia (USP) Reference Standard

别名:

N,N′′′-[(1,1-Dioxido-2H-1,2,4,6-thiatriazine-3,5-diyl)bis(2,1-ethanediylthiomethylene-4,2-thiazolediyl)]bisguanidine, 3,5-Bis[2-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]ethyl]-4H-1,2,4,6-thiatriazine 1,1-dioxide

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C16H23N11O2S5
CAS号:
分子量:
561.75
MDL號碼:
分類程式碼代碼:
41116107
NACRES:
NA.24
价格与库存信息目前不能提供

生物源

synthetic

等級

pharmaceutical primary standard

agency

USP

API 家族

famotidine

形狀

powder

包裝

pkg of 25 mg

製造商/商標名

USP

儲存條件

protect from light

顏色

yellow to white

溶解度

water: soluble

應用

pharmaceutical (small molecule)

形式

neat

InChI

1S/C16H23N11O2S5/c17-13(18)24-15-21-9(7-32-15)5-30-3-1-11-23-12(27-34(28,29)26-11)2-4-31-6-10-8-33-16(22-10)25-14(19)20/h7-8H,1-6H2,(H,23,26,27)(H4,17,18,21,24)(H4,19,20,22,25)

InChI 密鑰

NRRXZFHNRLQONH-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

一般說明

Famotidine Related Compound B (Famotidine Impurity B) is an impurity of famotidine, which is a hydrophilic, cationic, histamine H2 receptor antagonist drug that effectively inhibits gastric acid secretion in humans.[1][2][3]

應用

Famotidine Related Compound B USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monograph such as Famotidine

分析報告

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

其他說明

Sales restrictions may apply.

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

High-performance thin-layer chromatography for the determination of ranitidine hydrochloride and famotidine in pharmaceuticals.
Novakovic J.
Journal of Chromatography A, 846(1-2), 193-198 (1999)
Famotidine
Pharmacopeia, US
United States Pharmacopeia, 39(1)(1-2), 1815-1815 (2020)
Capillary zone electrophoresis method for the determination of famotidine and related impurities in pharmaceuticals
Helali N, et al.
Talanta, 74(4) (2008)
RP-HPLC determination of famotidine and its potential impurities in pharmaceuticals
Helali N, et al.
Chromatographia, 60(7-8) (2004)
Potentiometric determination of famotidine in pharmaceutical formulations
Ayad MM, et al.
Journal of Pharmaceutical and Biomedical Analysis, 29(1-2) (2002)

Questions

Reviews

No rating value

Active Filters

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门